Peter Meintjes
Chief Executive Officer en PACIFIC EDGE LIMITED .
Fortuna: 19 625 $ al 31/03/2024
Perfil
Peter Meintjes is currently the Chief Executive Officer at Pacific Edge Ltd.
Prior to this, he was the Chief Executive Officer at Omixon Biocomputing Kft.
He received his doctorate degree from Auckland University in 2008 and also completed his undergraduate and graduate degrees at Auckland University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
PACIFIC EDGE LIMITED
0.05% | 25/10/2023 | 386 016 ( 0.05% ) | 19 625 $ | 31/03/2024 |
Cargos activos de Peter Meintjes
Empresas | Cargo | Inicio |
---|---|---|
PACIFIC EDGE LIMITED | Chief Executive Officer | 17/01/2022 |
Antiguos cargos conocidos de Peter Meintjes.
Empresas | Cargo | Fin |
---|---|---|
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Chief Executive Officer | 20/04/2020 |
Formación de Peter Meintjes.
Auckland University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PACIFIC EDGE LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Omixon Biocomputing Kft. provides diagnostics services. The firm specializes in data analysis, next-generation sequencing, software development, amplicon sequencing, NGS, HLA typing, HLA Assay and Software, Whole Gene Sequencing, Whole Exome Sequencing, HLA Genotyping kit, Omixon Academy, automation, epitope matching, and molecular diagnostics. The company was founded by Attila Berces and Márton Szoke in 2011 and is headquartered in Budapest, Hungary. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Meintjes